Ambu A/S (OTCMKTS:AMBBY) Sees Large Volume Increase – Time to Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares saw an uptick in trading volume on Thursday. Approximately 1,000 shares were traded during mid-day trading, an increase of 55% from the average daily volume of 644 shares. The stock last traded at $13.60 and had previously closed at $12.10.

Wall Street Analyst Weigh In

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One investment analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Ambu A/S Price Performance

The company has a 50 day simple moving average of $11.04 and a 200 day simple moving average of $10.99. The company has a market capitalization of $3.20 billion, a price-to-earnings ratio of 45.33 and a beta of 0.86. The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY) last issued its earnings results on Thursday, November 5th. The company reported $0.14 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.